⚠ BETA β€” all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 16, 2026

NSE

Concord Biotech LimitedCONCORDBIO

Nifty Smallcap 250

Concord Biotech Limited is an NSE-listed company (CONCORDBIO).

AI-generated overview β€” verify before relying on it.

Net institutional flow

+β‚Ή331 Cr

Institutional buyers

2 in / 0 out

High-impact filings

1 Β· tilt Bullish

Next corporate action

β€”

Competitive landscape β€” the read

vs mapped peers
Institutional money is backing CONCORDBIO hardest (+β‚Ή331 Cr net). CONCORDBIO leads this set on institutional accumulation. Filing momentum favours CONCORDBIO (+1). News & social buzz is most positive on ACUTAAS.
#CompanyInst. flow β‚ΉCrDealsHi-impactFiling mom.BuzzNews
1CONCORDBIOThis+β‚Ή331 Cr51+1β€”β€”
2ACUTAAS+β‚Ή98.2 Cr1β€”β€”+46
3AAVAS+β‚Ή79.7 Cr5β€”β€”β€”β€”
4AADHARHFCβ€”β€”β€”β€”β€”β€”
5AARTIIND+β‚Ή0 Cr4β€”β€”β€”β€”
6ACE+β‚Ή0 Cr2β€”β€”β€”β€”
7ACMESOLARβˆ’β‚Ή80.9 Cr1β€”β€”+36
8ABLBLβˆ’β‚Ή314.4 Cr29β€”β€”β€”β€”
9ABFRLβˆ’β‚Ή730.3 Cr13β€”+1β€”β€”

Ranked by net institutional flow (buys βˆ’ sells, β‚ΉCr). Filing momentum = bullish βˆ’ bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline β€” CONCORDBIO day by day

Merged from deals, filings, corporate actions and news β€” newest first. Scope the deal/action portion with the period chips below.

Filings that matter

  • 2
    Investor CallNeutral

    Schedule of meet

    Source PDF β†’
  • 2
    UpdatesNeutral

    Completion of ANVISA Inspection conducted by the Brazilian Health Regulatory Agency at the Limbasi API Manufacturing Facility'.

    Source PDF β†’
  • 8
    Order WinBullish

    ANDA approval likely boosts Concord Biotech's US market presence.

    Source PDF β†’

Bulk & block deals

No bulk/block deals for CONCORDBIO in this window.

Results & transcripts

News & chatter on CONCORDBIO

RSS News

0

No recent news.

Google News RSS β€” links open the source.

The Dispatch

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.